Incannex Healthcare Halted, News Pending
On May 14, 2025, Rayonier Advanced Materials (NYSE:RYAM) Inc. held its Annual Meeting of Stockholders, where several key proposals were voted upon. The company, a leader in the pulp mills industry with a market capitalization of $271 million, announced the election of three director nominees to terms expiring in 2028. Trading at a Price/Book ratio of just 0.39, InvestingPro analysis suggests the stock is currently undervalued, despite experiencing a challenging period with a 57% decline over the past six months. However, stockholders did not approve the proposed amendments to declassify the board of directors and to eliminate the supermajority voting provisions in the company’s Amended and Restated Certificate of Incorporation. According to InvestingPro data, the company maintains a solid financial health score of 2.79 (labeled as "GOOD"), with 10+ additional exclusive insights available to subscribers through the comprehensive Pro Research Report.
The compensation of the company’s named executive officers was approved on an advisory basis, and the Rayonier Advanced Materials Inc. 2023 Incentive Stock Plan, as amended and restated, received approval as well. Additionally, the selection of Grant Thornton LLP as the company’s independent registered public accounting firm for the year 2025 was ratified.
The detailed voting results for each proposal were as follows:
1. Election of Directors, Terms Expire in 2028:
- Lisa M. Palumbo: 39,636,853 votes for, 4,965,058 against, 50,686 abstained, 10,924,043 broker non-votes.
- Ivona Smith: 39,436,587 votes for, 5,162,948 against, 53,062 abstained, 10,924,043 broker non-votes.
- Bryan D. Yokley: 44,411,989 votes for, 189,416 against, 51,192 abstained, 10,924,043 broker non-votes.
2. Amendment to Declassify the Board of Directors: 44,347,568 votes for, 274,927 against, 30,102 abstained, 10,924,043 broker non-votes.
3. Amendment to Eliminate Supermajority Voting Provisions: 44,163,083 votes for, 462,741 against, 26,773 abstained, 10,924,043 broker non-votes.
4. Advisory Vote on Compensation of Named Executive Officers: 43,763,003 votes for, 838,681 against, 50,913 abstained, 10,924,043 broker non-votes.
5. 2023 Incentive Stock Plan, as Amended and Restated: 40,641,326 votes for, 3,937,750 against, 73,521 abstained, 10,924,043 broker non-votes.
6. Ratification of Auditor: 55,026,432 votes for, 474,954 against, 75,254 abstained.
The company’s filing with the Securities and Exchange Commission (SEC) on May 16, 2025, provides these voting outcomes, reflecting the stockholders’ decisions on the governance and oversight of the company. Looking ahead, analysts maintain a consensus "Hold" recommendation, with price targets ranging from $6 to $7 per share, suggesting potential upside from current levels. The company’s next earnings report is scheduled for August 12, 2025, where investors will be watching for improvements in the company’s gross profit margin, which currently stands at 9.56%.
In other recent news, Rayonier Advanced Materials reported its first-quarter 2025 financial results, revealing significant challenges. The company posted an earnings per share of -$0.49, falling short of the anticipated $0.04, while revenue totaled $356 million, below the expected $395.75 million. Rayonier Advanced Materials has revised its full-year adjusted EBITDA guidance to $175-185 million, down from previous expectations. The company faced operational difficulties, including equipment failures and maintenance outages, which contributed to its financial performance. Analysts have shown concern over these results, reflecting broader market apprehensions about the company’s future targets. Despite these challenges, Rayonier Advanced Materials is focusing on its biomaterials strategy and exploring alternative markets to address the impact of tariffs on its cellulose commodities. The company remains optimistic about achieving its long-term EBITDA target of $325 million. Rayonier Advanced Materials’ liquidity stands at $272 million, with a net secured debt of $624 million.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.